Analystreport

Fate Therapeutics (NASDAQ: FATE) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating.

Fate Therapeutics, Inc.  (FATE) 
Last fate therapeutics, inc. earnings: 3/2 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.fatetherapeutics.com/investor-relations